Who owns HALOZYME THERAPEUTICS, INC. (HALO)? Elite investor 13F holders
7 tracked elite investors reported holding HALOZYME THERAPEUTICS, INC as of 2026-06-30, including D.E. Shaw, Gotham Asset Management, Renaissance Technologies LLC, Bridgewater Associates, Torray Funds. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
7 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| D.E. Shaw | HALOZYME THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 157047112.00 USD | 2006479.000000 | Shares | add | Original filing |
| Gotham Asset Management | HALOZYME THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 57862898.00 USD | 739273.000000 | Shares | reduce | Original filing |
| Renaissance Technologies LLC | HALOZYME THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 37539153.00 USD | 479611.000000 | Shares | reduce | Original filing |
| Bridgewater Associates | HALOZYME THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 36250437.00 USD | 463146.000000 | Shares | reduce | Original filing |
| Torray Funds | HALOZYME THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-07-30 00:00:00 | 3029284.00 USD | 38703.000000 | Shares | add | Original filing |
| Pzena Investment Management | HALOZYME THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-07 00:00:00 | 316915.00 USD | 4049.000000 | Shares | hold | Original filing |
| Ancora Advisors / Ancora Holdings | HALOZYME THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 8845.00 USD | 113.000000 | Shares | hold | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.